Loading Events

« All Events

  • This event has passed.

Controlling Product Access (Available Soon)

March 11, 2021

$650

Program Description

The topics discussed during this foundational program focus on product access, and go into detail on:

  • How insurance policies are built around controlling the use of healthcare services and drugs​
  • The tools used by insurance companies to control access to drugs

Program Structure

Upon registration, you will be assigned a set of e-learning courses to complete prior to the live webinar. These courses
will detail key topics related to transactions between stakeholders:

  • The Managed Care Landscape
  • Trends in Benefit Design​
  • Cost Containment Strategies

Pull-through Live Discussion

Insurance companies constantly balance keeping their beneficiaries healthy with the cost of delivering healthcare. Their efforts start with the way they design the benefits offered in their insurance policies. Those efforts continue as they apply tools like prior authorizations and step edits to the pharmacy benefit. This live discussion reviews all those topics and reviews their application in current payer strategies. Be prepared to discuss the product access environment in your territory

What to Expect​

Once you purchase a MAP Program, you will receive 3 emails from ProFusion MAP:​

  • Welcome! Learning Awaits​
    • This email will provide you with account information for access to the MAP Program you registered for​
  • Register for…
    • This email will list all available live webinar sessions for the MAP Program you purchased​
    • Sessions are closed to registration after the 10-person max is reached. Sign up early!​
  • You’re enrolled in…​
    • This email will direct you to the MAP Program with all e-learning courses to complete before your live session​
    • These courses are only available for 90 days after your purchase date. You are encouraged to complete all courses prior to the live session​

​Tip: You can save the ProFusion MAP LMS to your bookmark for quick access!​

If you have any questions, contact ProFusion MAP Support at +1 877-369-2580​

Stay Updated on New MAP Programs and Dates

As the market access environment changes, relevant topics will be covered through new programs. Subscribe below to be the first to know about new MAP Program topics and added dates for existing Programs.

*required





    Privacy Guaranteed — We will never share your info!

    Manufacturers Restricting 340B Sales to Contract Pharmacies

    • Abbvie
    • Amgen
    • AstraZeneca
    • Boehringer Ingelheim
    • Eli Lilly
    • Merck
    • Novartis
    • Novo Nordisk
    • Sanofi
    • UCB
    • United Therapeutics
    • and more…